| 5OQ5: reference: Design of Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors Using a Crystallographic Surrogate Derived from Checkpoint Kinase 1 (CHK1)., Williamson DS, Smith GP, Acheson-Dossang P, Bedford ST, Chell V, Chen IJ, Daechsel JCA, Daniels Z, David L, Dokurno P, Hentzer M, Herzig MC, Hubbard RE, Moore JD, Murray JB, Newland S, Ray SC, Shaw T, Surgenor AE, Terry L, Thirstrup K, Wang Y, Christensen KV, J Med Chem. 2017 Oct 12. doi: 10.1021/acs.jmedchem.7b01186. PMID: 29023112 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).